VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)

39 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q4 2019.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,171,123 shares of 107,573,681 outstanding shares and own 2.9% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (1,818,494 shares), VANGUARD GROUP INC (321,256 shares), BRIDGEWAY CAPITAL MANAGEMENT INC (224,400 shares), GEODE CAPITAL MANAGEMENT, LLC (204,833 shares), MORGAN STANLEY (200,725 shares), RENAISSANCE TECHNOLOGIES LLC (52,300 shares), LADENBURG THALMANN FINANCIAL SERVICES INC. (36,500 shares), NORTHERN TRUST CORP (35,061 shares), Bank of New York Mellon Corp (26,617 shares), and Aristides Capital LLC (23,052 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.